
{"id":13785,"date":"2022-01-13T11:41:23","date_gmt":"2022-01-13T11:41:23","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/notre-nouveau-president-dr-charles-woler\/"},"modified":"2026-02-11T09:49:34","modified_gmt":"2026-02-11T09:49:34","slug":"notre-nouveau-president-dr-charles-woler","status":"publish","type":"post","link":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/","title":{"rendered":"Notre nouveau pr\u00e9sident : Dr Charles Woler"},"content":{"rendered":"<p>Nous avons nomm\u00e9 le Dr Charles Woler, dirigeant pharmaceutique tr\u00e8s exp\u00e9riment\u00e9, au poste de pr\u00e9sident.<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-12532\" src=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Charles-Woler.jpg\" alt=\"Dr Charles Woler\"><\/p>\n<p>&nbsp;<\/p>\n<p>Au cours de sa longue carri\u00e8re, Charles a occup\u00e9 plusieurs postes cl\u00e9s dans le secteur, notamment celui de PDG de Roche France, de pr\u00e9sident ex\u00e9cutif pour l&rsquo;Europe de SmithKline Beecham PLC et de PDG de Cadus Pharmaceutical aux \u00c9tats-Unis.<\/p>\n<p>Il a \u00e9galement travaill\u00e9 dans de nombreuses soci\u00e9t\u00e9s de capital-risque sp\u00e9cialis\u00e9es dans les biotechnologies, a pr\u00e9sid\u00e9 le comit\u00e9 consultatif du fonds d&rsquo;investissement public-priv\u00e9 Inserm-Transfert Initiative et a \u00e9t\u00e9 vice-pr\u00e9sident de l&rsquo;association professionnelle France Biotech pendant trois ans.<\/p>\n<p>Par ailleurs, Charles a cr\u00e9\u00e9 la soci\u00e9t\u00e9 de biotechnologie fran\u00e7aise Neuro3d avant de la revendre, a cofond\u00e9 la soci\u00e9t\u00e9 biopharmaceutique suisse Inflamalps et a \u00e9t\u00e9 PDG de Biomnis, l&rsquo;un des plus grands laboratoires ind\u00e9pendants d&rsquo;Europe.<\/p>\n<p>Il a obtenu un doctorat en pharmacologie clinique de l&rsquo;Universit\u00e9 de Lyon et un doctorat en m\u00e9decine de l&rsquo;Universit\u00e9 Paris Diderot (Paris VII), et a depuis pass\u00e9 plus de 35 ans dans les secteurs pharmaceutique, biotechnologique et m\u00e9dical en Europe et en Am\u00e9rique du Nord.<\/p>\n<p>Charles rejoint Sygnature Discovery suite \u00e0 notre <a href=\"https:\/\/www.sygnaturediscovery.com\/news-and-events\/news\/five-arrows-invests-in-sygnature-discovery\/\">important investissement<\/a> de Five Arrows Principal Investments, la branche europ\u00e9enne de capital-investissement de Rothschild &amp; Co, en 2021.<\/p>\n<p>En moins de quatre ans, nous sommes pass\u00e9s de 200 \u00e0 plus de 500 employ\u00e9s et avons ouvert un deuxi\u00e8me bureau am\u00e9ricain \u00e0 South San Francisco en avril dernier.<\/p>\n<p>Le Dr Charles Woler, pr\u00e9sident de Sygnature Discovery, a d\u00e9clar\u00e9 : \u00ab J&rsquo;admire Sygnature Discovery depuis longtemps, ayant d\u00e9j\u00e0 effectu\u00e9 une analyse approfondie de l&rsquo;entreprise dans le cadre d&rsquo;\u00e9tudes sur les possibilit\u00e9s d&rsquo;investissement lorsque je travaillais dans le secteur du capital-investissement. Je suis donc ravi de rejoindre une organisation aussi performante et ambitieuse. \u00bb<\/p>\n<p>\u00ab Sygnature jouit d\u2019une r\u00e9putation d\u2019excellence en mati\u00e8re de travail scientifique, d\u2019une culture favorisant une communication et une collaboration tr\u00e8s efficaces, et d\u2019une exp\u00e9rience av\u00e9r\u00e9e dans le d\u00e9veloppement de compos\u00e9s jusqu\u2019aux essais cliniques. \u00bb<\/p>\n<p>\u00ab Je crois que c\u2019est une entreprise qui a un bel avenir devant elle, et je me r\u00e9jouis de contribuer \u00e0 la r\u00e9alisation de son immense potentiel \u00e0 un moment aussi passionnant dans le monde de la d\u00e9couverte de m\u00e9dicaments. \u00bb<\/p>\n<p>Le Dr Simon Hirst, PDG et fondateur de Sygnature Discovery, a d\u00e9clar\u00e9 : \u00ab Nous sommes ravis de collaborer avec Charles dans cette nouvelle phase d&rsquo;investissement. Charles poss\u00e8de une vaste connaissance et une solide exp\u00e9rience du secteur pharmaceutique, acquises \u00e0 diff\u00e9rents postes de direction, de recherche et d\u00e9veloppement, de vente et de gestion. \u00bb <\/p>\n<p>\u00ab Il contribuera \u00e0 d\u00e9finir l\u2019approche strat\u00e9gique de notre entreprise florissante de d\u00e9couverte de m\u00e9dicaments, alors que nous cherchons \u00e0 acc\u00e9l\u00e9rer notre croissance et \u00e0 am\u00e9liorer continuellement notre offre de services \u00e0 nos clients. \u00bb<\/p>\n<p>En tant que pr\u00e9sident, Charles souhaite vivement soutenir nos efforts de recrutement, \u00e9largir nos domaines th\u00e9rapeutiques, d\u00e9velopper notre pr\u00e9sence en Am\u00e9rique du Nord et exploiter le potentiel de l&rsquo;IA et de l&rsquo;apprentissage automatique dans la d\u00e9couverte de m\u00e9dicaments.<\/p>\n<p>En plus de ses nouvelles fonctions, Charles occupe \u00e9galement plusieurs postes au sein des conseils d&rsquo;administration d&rsquo;autres organisations, notamment celui de pr\u00e9sident de la soci\u00e9t\u00e9 de biotechnologie fran\u00e7aise DEINOVE et celui d&rsquo;administrateur non ex\u00e9cutif de la CRO croate Optimapharm.<\/p>\n<p>Si vous souhaitez discuter de la mani\u00e8re dont nous pouvons acc\u00e9l\u00e9rer votre projet de d\u00e9couverte de m\u00e9dicaments jusqu&rsquo;\u00e0 la phase clinique, contactez-nous via l&rsquo;un de nos <a href=\"https:\/\/www.sygnaturediscovery.com\/contact\/\">formulaires de contact<\/a> .<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":13786,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"category":[29],"tags":[],"class_list":["post-13785","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-categorise"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Notre nouveau pr\u00e9sident : Dr Charles Woler - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notre nouveau pr\u00e9sident : Dr Charles Woler - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-13T11:41:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-11T09:49:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1448\" \/>\n\t<meta property=\"og:image:height\" content=\"1447\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"pnpd-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"pnpd-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/\"},\"author\":{\"name\":\"pnpd-admin\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448\"},\"headline\":\"Notre nouveau pr\u00e9sident : Dr Charles Woler\",\"datePublished\":\"2022-01-13T11:41:23+00:00\",\"dateModified\":\"2026-02-11T09:49:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/\"},\"wordCount\":627,\"publisher\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg\",\"articleSection\":[\"Non cat\u00e9goris\u00e9\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/\",\"name\":\"Notre nouveau pr\u00e9sident : Dr Charles Woler - Sygnature\",\"isPartOf\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg\",\"datePublished\":\"2022-01-13T11:41:23+00:00\",\"dateModified\":\"2026-02-11T09:49:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#primaryimage\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg\",\"contentUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg\",\"width\":1448,\"height\":1447},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notre nouveau pr\u00e9sident : Dr Charles Woler\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#website\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg\",\"contentUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448\",\"name\":\"pnpd-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"caption\":\"pnpd-admin\"},\"sameAs\":[\"http:\/\/www.sygnaturediscovery.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notre nouveau pr\u00e9sident : Dr Charles Woler - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/","og_locale":"fr_CA","og_type":"article","og_title":"Notre nouveau pr\u00e9sident : Dr Charles Woler - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/","og_site_name":"Sygnature","article_published_time":"2022-01-13T11:41:23+00:00","article_modified_time":"2026-02-11T09:49:34+00:00","og_image":[{"width":1448,"height":1447,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg","type":"image\/jpeg"}],"author":"pnpd-admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"pnpd-admin","Estimation du temps de lecture":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#article","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/"},"author":{"name":"pnpd-admin","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448"},"headline":"Notre nouveau pr\u00e9sident : Dr Charles Woler","datePublished":"2022-01-13T11:41:23+00:00","dateModified":"2026-02-11T09:49:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/"},"wordCount":627,"publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg","articleSection":["Non cat\u00e9goris\u00e9"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/","name":"Notre nouveau pr\u00e9sident : Dr Charles Woler - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg","datePublished":"2022-01-13T11:41:23+00:00","dateModified":"2026-02-11T09:49:34+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/sygnature-discovery-building-e1521121985887.jpg","width":1448,"height":1447},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/notre-nouveau-president-dr-charles-woler\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Notre nouveau pr\u00e9sident : Dr Charles Woler"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448","name":"pnpd-admin","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","caption":"pnpd-admin"},"sameAs":["http:\/\/www.sygnaturediscovery.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/comments?post=13785"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13785\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13786"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/tags?post=13785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}